We are improving the lives of people suffering from mental illness and substance use disorders
What we do
HQ & Pipeline
At the core of a sustainable society
are health and well-being, the areas where
Orexo makes its biggest impact.
MAY 9, 2023
Fentanyl Awareness Day 2023: "Fentanyl is in everything and it’s killing so many people."
APRIL 27, 2023
Orexo Interim Report Q1 2023
APRIL 26, 2023
Presentation of Orexo's Q1 Interim Report 2023 - April 27 at 2 pm
amorphOX® – a versatile drug delivery platform
Orexo’s novel drug delivery platform has unique properties for the development of differentiated pharmaceuticals that need to be absorbed rapidly by the body and remain stable over time.
Press Releases & News
Group net revenues
US Pharma segment EBIT
1 Last Twelve Months, Q222-Q123, for more information about financial development Link
Glad to have these colleagues presenting the amorphOX® drug delivery platform at the Novel Nasal Formulation & Deli… https://t.co/bLVUITar8c
Tomorrow we will join Bolagsdagen hosted by Erik Penser Bank. An IRL event with more than 300 participants + 60 pre… https://t.co/l2M5u5w8CO
Our partner @gesynta Pharma is developing a novel treatment for #endometriosis (phase II). Today they announces the… https://t.co/Ue74yAbNJ1